Benzinga | Nov 3, 2021 09:18AM EDT

Clovis Oncology Q3 EPS $(0.56) Misses $(0.48) Estimate, Sales $37.92M Miss $39.09M Estimate

Clovis Oncology (NASDAQ:CLVS) reported quarterly losses of $(0.56) per share which missed the analyst consensus estimate of $(0.48) by 16.67 percent. This is a 37.08 percent increase over losses of $(0.89) per share from the same period last year. The company reported quarterly sales of $37.92 million which missed the analyst consensus estimate of $39.09 million by 3.00 percent. This is a 2.21 percent decrease over sales of $38.77 million the same period last year.